Home/Filings/4/0001683168-26-000016
4//SEC Filing

Levin Rami 4

Accession 0001683168-26-000016

CIK 0001729427other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 5:01 PM ET

Size

5.9 KB

Accession

0001683168-26-000016

Insider Transaction Report

Form 4
Period: 2026-01-01
Levin Rami
DirectorCEO and President
Transactions
  • Award

    Restricted Stock Units

    2026-01-01+19,00019,000 total
    Exp: 2036-01-01Common Stock (19,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Company common stock.
  • [F2]The restricted stock units set forth in the table vest as follows: 25% on the six-month anniversary of the transaction date, 25% on the twelve-month anniversary of the transaction date, and the remaining 50% in twelve quarterly installments thereafter, subject to the reporting person's continued employment on each vesting date.
  • [F3]Issued in connection with the reporting person's employment with the Company.

Documents

1 file

Issuer

CNS Pharmaceuticals, Inc.

CIK 0001729427

Entity typeother

Related Parties

1
  • filerCIK 0002102719

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:01 PM ET
Size
5.9 KB